{"gene":"RIPK3","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1999,"finding":"RIP3 (RIPK3) is a novel kinase containing an N-terminal kinase domain homologous to RIP and RIP2, but with a unique C-terminus. RIP3 binds RIP1 through its unique C-terminal segment, is recruited to the TNF receptor-1 signaling complex, and attenuates RIP1- and TNFR1-induced NF-κB activation. Overexpression induces apoptosis via selective binding to large prodomain initiator caspases.","method":"Co-immunoprecipitation, overexpression, NF-κB reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal binding assays and functional NF-κB reporter, single lab, foundational characterization paper","pmids":["10358032"],"is_preprint":false},{"year":2010,"finding":"Murine cytomegalovirus (MCMV) infection induces RIP3-dependent necrosis. RIP3 kinase activity and RHIM-dependent interactions control virus-associated necrosis; this death proceeds independently of RIP1, distinguishing it from TNFα-induced necroptosis. The viral M45-encoded inhibitor vIRA targets RIP3 and disrupts RIP3-RIP1 interactions, suppressing both TNF-induced and virus-induced necroptosis.","method":"Genetic knockout (RIP3-deficient mice), viral infection models, co-immunoprecipitation, in vivo attenuation studies","journal":"Cell host & microbe","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined phenotype, mechanistic interaction studies, in vivo validation, replicated across infection contexts","pmids":["20413098"],"is_preprint":false},{"year":2011,"finding":"Genetic deficiency of RIP3 (RIPK3) prevents spontaneous epithelial cell necrosis, Paneth cell loss, and colitis in FADD-deficient intestinal epithelial cell-specific knockout mice, demonstrating that RIP3-dependent programmed necrosis drives intestinal inflammation when FADD-mediated apoptotic signaling is absent.","method":"Genetic epistasis (double-knockout mice: FADD IEC-KO × RIP3 KO), histopathology","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis in vivo with defined phenotypic readout, published in high-impact journal","pmids":["21804564"],"is_preprint":false},{"year":2012,"finding":"Quantitative phosphoproteomic analysis (SILAC) comparing RIP3+/+ and RIP3−/− cells identified a potential RIP3 phosphorylation motif and a broad set of RIP3-regulated phosphoproteins spanning cell cycle, metabolism, and development, suggesting RIP3 kinase activity controls phosphorylation of substrates beyond direct necroptotic effectors.","method":"Quantitative phosphoproteomics (SILAC + IMAC-HILIC + nanoLC-MS/MS) in macrophages and MEFs","journal":"Molecular & cellular proteomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic phosphoproteomic screen with KO control, single lab, identifies substrate motif and broad substrate set","pmids":["22942356"],"is_preprint":false},{"year":2013,"finding":"Phosphorylation of RIP3 at S204 creates a phosphomimetic (S204D) that drives programmed necrosis independently of RIP1 and necrostatin-1. Mutation of RIP1 S89 to alanine enhances RIP1 kinase activity and necrosis without affecting necrosome formation, identifying S89 as an inhibitory phosphosite on RIP1 upstream of RIP3.","method":"Site-directed mutagenesis, cell death assays, siRNA knockdown, kinase activity assays","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional readout, single lab, two orthogonal methods","pmids":["24059293"],"is_preprint":false},{"year":2014,"finding":"RIP3 dimerization leads to RIP3 intramolecular autophosphorylation; phosphorylation of one RIP3 molecule within a dimer is sufficient for MLKL recruitment and necroptosis induction. RIP1-RIP3 heterodimers alone cannot trigger necroptosis without recruitment of additional RIP3; RIP3-RIP3 homo-interaction is the critical event for necroptosis execution.","method":"Inducible dimerization systems (chemical-inducible FKBP/rapamycin), phosphorylation assays, MLKL recruitment assays, cell death assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with inducible dimerization, mutagenesis, multiple orthogonal readouts in one study","pmids":["24902902"],"is_preprint":false},{"year":2014,"finding":"RIPK1 both activates RIPK3 (via RHIM-dependent oligomerization in response to TNF signaling) and negatively regulates spontaneous RIPK3 oligomerization in the cytosol. Chemically enforced RIPK3 oligomerization triggers necroptosis independent of RHIM domain, TNF, or RIPK1 kinase activity. Caspase-8 controls propagation/stability of RIPK3 dimers seeded by RHIM interactions.","method":"Inducible dimerization/oligomerization constructs, RIPK1 KO cells, chemical inhibition of RIPK1, cell death assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with engineered constructs, KO controls, multiple orthogonal methods in one study","pmids":["24902904"],"is_preprint":false},{"year":2014,"finding":"Three selective RIP3 kinase inhibitors inhibit necroptosis but, at higher concentrations, induce apoptosis via RHIM-driven recruitment of RIP1 to form a RIP3-FADD-caspase-8-cFLIP complex, independent of pronecrotic kinase activities and MLKL. A kinase-dead D161N RIP3 mutant spontaneously induces apoptosis, while K51A does not — RIP3 D161N/D161N mice die perinatally but RIP3 K51A/K51A mice are viable.","method":"Small-molecule inhibitors, kinase-dead mutants, RHIM mutagenesis, caspase-8 complex co-immunoprecipitation, knock-in mice","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple compounds, mutagenesis, knock-in mice, Co-IP of complex, multiple orthogonal methods","pmids":["25459880"],"is_preprint":false},{"year":2015,"finding":"In the absence of IAPs, LPS triggers RIPK3 to activate caspase-8 and promote apoptosis and NLRP3-caspase-1 activation independently of RIPK3 kinase activity and MLKL. When both IAPs and caspase-8 are absent, RIPK3 kinase activity and MLKL are required for TLR-induced NLRP3 activation. TRIF and IAPs regulate RIPK3 and MLKL ubiquitylation.","method":"Genetic KO models (IAP-deficient, caspase-8 KO, MLKL KO, RIPK3 KO), LPS treatment, inflammasome activation assays, in vivo arthritis model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic KO combinations with defined mechanistic outcomes, in vivo validation, two independent epistasis results","pmids":["25693118"],"is_preprint":false},{"year":2016,"finding":"RIP3 triggers myocardial necroptosis through activation of CaMKII (via phosphorylation or oxidation), rather than through RIP1 and MLKL, leading to mitochondrial permeability transition pore (mPTP) opening. RIP3 deficiency or CaMKII inhibition ameliorates ischemia-reperfusion and doxorubicin-induced myocardial necroptosis and heart failure in mice.","method":"RIP3 KO mice, CaMKII inhibition (genetic and pharmacologic), cardiac ischemia-reperfusion models, co-immunoprecipitation, phosphorylation assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple in vivo models, KO validation, pharmacologic confirmation, identification of CaMKII as RIP3 substrate","pmids":["26726877"],"is_preprint":false},{"year":2016,"finding":"Proteasome inhibitors (MG132, bortezomib) activate RIPK3-MLKL necroptotic pathway in a RHIM-dependent but caspase-inhibition-independent manner. K48-linked ubiquitination of RIPK3 (partially at K264) accumulates upon proteasome inhibition. When MLKL recruitment to RIPK3 is restricted under proteasome inhibition, RIPK3-dependent apoptosis is induced instead.","method":"Proteasome inhibitor treatment, RHIM mutagenesis, K264R ubiquitination mutants, cell death assays, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis and pharmacologic dissection, single lab, two orthogonal methods","pmids":["26786097"],"is_preprint":false},{"year":2016,"finding":"RIPK1 and RIPK3 kinase activities promote sustained activation of Erk, cFos, and NF-κB to drive pro-inflammatory gene expression in macrophages stimulated by LPS, independently of cell death functions. This regulation requires the adaptor TRIF and proceeds cell-autonomously.","method":"Kinase inhibitors, genetic KO, LPS stimulation of primary macrophages, cytokine/signaling assays, in vivo LPS challenge","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacologic tools, defined downstream signaling readouts, in vivo validation, single lab","pmids":["27396959"],"is_preprint":false},{"year":2017,"finding":"RIPK3 restricts West Nile virus pathogenesis in the CNS independently of necroptotic cell death: Ripk3−/− mice show enhanced mortality with suppressed neuronal chemokine expression and decreased CNS recruitment of T lymphocytes and inflammatory myeloid cells, while Mlkl−/− mice are unaffected, demonstrating a death-independent neuroinflammatory signaling role for RIPK3.","method":"Ripk3−/− and Mlkl−/− mouse models, WNV infection, flow cytometry, chemokine profiling","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dissection using KO for both RIPK3 and MLKL with defined phenotypic readouts, rigorous controls, published in Cell","pmids":["28366204"],"is_preprint":false},{"year":2017,"finding":"RIPK1 and RIPK3 kinase activities direct IFN-β synthesis induced by LPS via necrosome-like aggregates that facilitate canonical TRIF-dependent signaling downstream of TLR4, independently of MLKL and necroptosis.","method":"Genetic KO and kinase inhibitors, macrophage LPS stimulation, IFN-β ELISA, necrosome formation assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacologic dissection, defined downstream signaling endpoint, single lab","pmids":["28461567"],"is_preprint":false},{"year":2018,"finding":"PELI1 E3 ubiquitin ligase selectively targets kinase-active RIP3 for degradation: phosphorylation of RIP3 on T182 leads to interaction with the FHA domain of PELI1, which then mediates K48-linked polyubiquitination of RIP3 on K363, promoting proteasomal degradation and preventing cell death from RIP3 hyperactivation.","method":"Co-immunoprecipitation, ubiquitination assays, mutagenesis (T182, K363), in vitro kinase assays, cell death assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of ubiquitination, mutagenesis of key residues, multiple orthogonal methods, mechanistic link between phosphorylation and ubiquitination","pmids":["29883609"],"is_preprint":false},{"year":2018,"finding":"RIPK3 promotes kidney fibrosis through AKT-dependent activation of ATP citrate lyase (ACL), independently of MLKL-dependent necroptosis. RIPK3-deficient mice are protected from UUO- and adenine diet-induced fibrosis while MLKL-deficient mice are not. Genetic or chemical RIPK3 inhibition suppresses TGF-β1-induced AKT and ACL phosphorylation in fibroblasts.","method":"RIPK3 KO and MLKL KO mouse models, UUO/adenine diet fibrosis models, AKT/ACL phosphorylation assays, fibroblast TGF-β1 stimulation","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis comparing RIPK3 KO vs MLKL KO, in vitro mechanistic pathway, two in vivo models","pmids":["29415885"],"is_preprint":false},{"year":2018,"finding":"RIPK3 kinase domain homodimerizes through a surface structurally similar to RAF family members; mutation of the dimer interface residues impairs dimerization and necroptosis. Kinase domain dimerization drives cis-autophosphorylation of RIPK3 and is required for necroptosis. The D161N mutation enhances this noncatalytic allosteric dimerization function, explaining its apoptosis-inducing activity.","method":"Structural analysis, dimerization interface mutagenesis, co-immunoprecipitation, cell death assays, RIPK3 D161N heterozygous × RIPK1 KO mice","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural modeling plus mutagenesis of dimerization interface plus genetic mouse models, multiple orthogonal methods","pmids":["30131368"],"is_preprint":false},{"year":2018,"finding":"RIPK3 deficiency in TAMs reduces ROS and inhibits caspase-1-mediated cleavage of PPARγ, enabling PPARγ activation and fatty acid oxidation, thus driving M2 polarization and immunosuppression in the tumor microenvironment of hepatocellular carcinoma.","method":"RIPK3 KO macrophages, ROS assays, caspase-1 activity assays, PPARγ cleavage assays, macrophage polarization assays","journal":"Cancer immunology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined molecular readouts, mechanistic pathway dissection, single lab","pmids":["32122992"],"is_preprint":false},{"year":2019,"finding":"Neuronal ZBP1 and RIPK3 activation during Zika virus infection restricts viral replication by upregulating the enzyme IRG1 and producing the metabolite itaconate, which inhibits succinate dehydrogenase. This immunometabolic pathway operates independently of necroptotic cell death.","method":"ZBP1 KO and RIPK3 KO mouse models, Zika infection, metabolomics, IRG1 expression assays, succinate dehydrogenase activity assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with mechanistic metabolic pathway dissection, multiple orthogonal methods, ZBP1-RIPK3-IRG1-itaconate axis defined","pmids":["30635240"],"is_preprint":false},{"year":2019,"finding":"CK1γ1 and CK1γ3 promote TNF-induced necroptosis by forming a complex with the necrosome (RIPK1, RIPK3, MLKL) and phosphorylating RIPK3, affecting its activity. Autophosphorylated CK1γ3 (S344/345) is present in the necrosome. CK1γ is cleaved by caspase-8 during apoptosis, analogous to RIPK1.","method":"Gain-of-function kinase screen (546 kinases), Co-IP, in vitro kinase assays with purified proteins, siRNA knockdown, cell death assays, CK1γ inhibitor in vivo","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with purified proteins showing CK1γ phosphorylates RIPK3, plus Co-IP, single lab","pmids":["31801942"],"is_preprint":false},{"year":2020,"finding":"TRIM25 E3 ubiquitin ligase directly interacts with RIP3 through its SPRY domain and mediates K48-linked polyubiquitination of RIP3 at K501, promoting proteasomal degradation. The RING domain of TRIM25 is required for this ubiquitination. TRIM25 deficiency inhibits RIP3 ubiquitination and promotes TNF-induced cell necrosis.","method":"Co-immunoprecipitation, ubiquitination assays, TRIM25 KO cells, mutagenesis (K501R), domain-deletion analysis","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, mutagenesis, functional cell death assay; single lab, no in vitro reconstitution","pmids":["33953350"],"is_preprint":false},{"year":2021,"finding":"ZBP1 induces K63- and M1-linked ubiquitin chains on RIPK1 and ZBP1 itself through cIAP1 and LUBAC, using RIPK1 and RIPK3 as scaffolds (not through their kinase activity) to promote TAK1- and IKK-mediated inflammatory cytokine production, independently of cell death. ZBP1 associates with RIPK1, RIPK3, cIAP1, and LUBAC in HT29 cells.","method":"Co-immunoprecipitation, ubiquitin chain-type analysis, kinase inhibitors, caspase inhibitors, cytokine assays in HT29 cells","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP showing complex, ubiquitin chain characterization, kinase-independence demonstrated, single lab","pmids":["36268590"],"is_preprint":false},{"year":2021,"finding":"A class of orthopoxvirus proteins (vIRD — viral inducer of RIPK3 degradation) binds host SKP1-Cullin1-F-box (SCF) machinery and RIPK3, triggering ubiquitination and proteasome-mediated degradation of RIPK3 to inhibit necroptosis and regulate virus-induced inflammation.","method":"siRNA screen, Co-immunoprecipitation, ubiquitination assays, RIPK3 KO and MLKL KO mice, viral replication assays in vivo","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, ubiquitination assays, genetic KO validation in vivo, mechanism confirmed by rescue in RIPK3/MLKL KO mice","pmids":["33444549"],"is_preprint":false},{"year":2021,"finding":"Phosphorylated MLKL disengages from RIPK3 following necroptotic stimulation through a conformational transition of the MLKL pseudokinase domain. Monobody-27 binds MLKL via an epitope overlapping the RIPK3 binding site that is only exposed after pMLKL disengages from RIPK3, identifying MLKL disengagement from RIPK3 as a key regulatory step in necroptosis.","method":"Crystal structures of MLKL pseudokinase domain with Monobodies, cell-based necroptosis assays, phospho-MLKL pulldowns","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional cell-based validation, identifies RIPK3-MLKL disengagement as regulatory step","pmids":["33850121"],"is_preprint":false},{"year":2022,"finding":"RIPK3 phosphorylation at T224 and S227 (C-lobe) are synergistic, crucial sites for stable interaction with MLKL and promotion of necroptosis in human cells. Activation loop phosphorylation at S164/T165 negatively regulates RIPK3 kinase activity. Stable recruitment of MLKL by phospho-T224/S227 RIPK3 to the necrosome is an essential checkpoint independent of and prior to MLKL phosphorylation.","method":"Phosphoproteomics of RIPK3 in HT29 cells, mutagenesis of phosphosites, kinase-inactive RIPK3 controls, cell death assays","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphoproteomics plus systematic mutagenesis of 21 phosphosites, mechanistic dissection of RIPK3-MLKL interaction, multiple orthogonal methods","pmids":["35739084"],"is_preprint":false},{"year":2022,"finding":"Super-resolution microscopy reveals that cellular necrosomes are mosaic structures comprising alternating RIP1 and RIP3 oligomeric domains. Small mosaics are round; large functional mosaics are rod-shaped. RIP3 oligomers of tetramer size or above serve as domains for MLKL oligomerization driven by phospho-RIP3. RIP1 autophosphorylation controls ordered RIP1 oligomerization and is required for RIP1-initiated RIP3 homo-oligomerization in correct configuration for functional rod-shaped mosaic formation.","method":"Super-resolution microscopy (STORM/PALM), inducible dimer systems, RIP1 autophosphorylation mutants, MLKL recruitment assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — nanoscale structural imaging combined with functional mutagenesis and reconstitution, multiple orthogonal methods","pmids":["35256774"],"is_preprint":false},{"year":2022,"finding":"RIPK3 deficiency restores mitochondrial biogenesis, bioenergetics, and function in NAFLD, and is accompanied by upregulation of antioxidant systems and alterations in lipid droplet architecture (smaller, more numerous LDs). RIPK3 deficiency upregulates LD-associated proteins PLIN1 and PLIN5.","method":"Ripk3−/− mice on CDAA diet, CRISPR-Cas9 Ripk3-null hepatocytes, mitochondrial function assays, lipid droplet imaging, proteomics","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse and cell model, multiple metabolic readouts, single lab","pmids":["36029129"],"is_preprint":false},{"year":2022,"finding":"RIPK3 cleavage by caspase-8 at D333 is dispensable for blocking necroptosis during development (Ripk3D333A/D333A mice are viable), but caspase-8-mediated cleavage of RIPK3 restricts NLRP3 inflammasome activation, pyroptosis, and IL-1β secretion when IAPs are limiting.","method":"Knock-in mice (Ripk3D333A/D333A), cell death assays, NLRP3 inflammasome activation assays, IL-1β secretion","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — precise knock-in mouse model, defined mechanistic outcome separating necroptosis from inflammasome functions, rigorous controls","pmids":["38514849"],"is_preprint":false},{"year":2022,"finding":"RIPK3-MLKL signaling drives STING pathway amplification: RIPK3 inhibits autophagic degradation of STING, while MLKL (when its pro-necroptotic membrane activity is blocked) binds activated STING and is secreted extracellularly to restrict TBK1 and IRF3 recruitment, thereby bidirectionally regulating STING signaling.","method":"RIPK3 KO HT29 cells, autophagy flux assays, STING co-immunoprecipitation with MLKL, cell death assays, in vivo sepsis model","journal":"Clinical and translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO cells with defined molecular pathway, Co-IP of MLKL-STING complex, single lab","pmids":["37475188"],"is_preprint":false},{"year":2023,"finding":"OASL undergoes liquid-liquid phase condensation upon viral infection and scaffolds RIPK3 and ZBP1 via protein-protein interactions, providing spatial segregation for RIPK3 nucleation. This OASL-driven liquid platform facilitates amyloid-like fibril formation and autophosphorylation of RIPK3, leading to MLKL phosphorylation and necroptosis. Oasl1-deficient mice show severely impaired necroptosis and uncontrolled viral dissemination.","method":"Phase condensation assays, co-immunoprecipitation, RIPK3 fibril formation assays, MLKL phosphorylation, Oasl1 KO mice with viral infection","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution of phase condensation, amyloid fibrillation assays, KO mouse validation, multiple orthogonal methods","pmids":["36604592"],"is_preprint":false},{"year":2023,"finding":"PRMT1 methyltransferase methylates RIP3 at R486 (human) / R479 (mouse), and this methylation inhibits the RIP1-RIP3 interaction and suppresses necrosome complex formation, thereby blocking RIP3 phosphorylation and necroptosis activation.","method":"Co-immunoprecipitation, in vitro methylation assays, methylation-deficient RIP3 mutant, RIP3-RIP1 interaction assays, necroptosis readouts, patient sample analysis with di-methylation-specific antibody","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro methylation and Co-IP showing direct mechanistic consequence, single lab","pmids":["37005412"],"is_preprint":false},{"year":2023,"finding":"p55γ promotes RIP3 proteasomal degradation in a ubiquitin-dependent manner, with MG53 functioning as the E3 ligase mediating p55γ-induced RIP3 degradation. HIF1α transcriptionally regulates p55γ expression. This p55γ-MG53-RIP3 axis underlies ischemic preconditioning-induced suppression of myocardial necroptosis.","method":"Co-immunoprecipitation, pulldown assays, mass spectrometry, ChIP assays, p55γ transgenic and KO mice, cardiac I/R model","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and pulldown identifying MG53 as E3 ligase for RIP3, genetic mouse validation, single lab","pmids":["37527538"],"is_preprint":false},{"year":2024,"finding":"ZBP1 senses mitochondrial Z-form DNA induced by diquat poisoning in endothelial cells and interacts with RIPK3, leading to RIPK3-dependent necroptosis and ferroptosis. RIPK3 has a dual role: it phosphorylates MLKL (necroptosis) and also phosphorylates FSP1 to inhibit its enzymatic activity (promoting ferroptosis). Specific deletion of Zbp1 or Ripk3 in endothelial cells simultaneously inhibits both death pathways.","method":"Endothelial cell-specific Zbp1 and Ripk3 KO mice, Z-DNA detection, MLKL phosphorylation assays, FSP1 phosphorylation and activity assays, organ damage readouts","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-specific KO with dual pathway dissection, identification of FSP1 as a novel RIPK3 substrate, multiple orthogonal methods","pmids":["38493248"],"is_preprint":false},{"year":2024,"finding":"RIPK3 induces mitochondrial fission in diabetic podocytes via MLKL-PGAM5-Drp1 signaling: RIPK3 activates MLKL, which engages PGAM5 to promote phosphorylation and mitochondrial translocation of Drp1 (S616), causing mitochondrial fragmentation and dysfunction. Ripk3 KO mice are protected from DKD-associated albuminuria and podocyte loss.","method":"Ripk3 KO mice (DKD model), RIPK3 overexpression in podocytes, MLKL/PGAM5/Drp1 phosphorylation assays, mitochondrial imaging, single-cell RNA-seq","journal":"Metabolism: clinical and experimental","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model plus mechanistic pathway via MLKL-PGAM5-Drp1, single lab","pmids":["39089491"],"is_preprint":false},{"year":2016,"finding":"RIP3 nuclear translocation and formation of a RIP3-AIF complex, followed by nuclear translocation of this complex, is critical for ischemic neuronal DNA degradation and programmed necrosis after global cerebral ischemia/reperfusion injury in rats.","method":"Necrostatin-1 treatment, immunoprecipitation, immunofluorescence co-localization, western blot in rat I/R model","journal":"Scientific reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — co-immunoprecipitation and co-localization in single rat model, single lab, no genetic KO confirmation","pmids":["27377128"],"is_preprint":false},{"year":2022,"finding":"RIPK3-MLKL signaling activates mitochondrial CaMKII which drives phosphorylation of Smad2/3 and subsequent production of extracellular matrix proteins (αSMA, collagen 1α1) in response to TGF-β during chronic kidney disease. TGF-β induces translocation of RIPK3 and MLKL to mitochondria, causing mitochondrial dysfunction and ROS production that activates CaMKII.","method":"RIPK3 KO and MLKL KD experiments, mitochondrial fractionation, CaMKII inhibition, Smad2/3 phosphorylation assays, UUO model","journal":"Matrix biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO/KD with defined downstream phosphorylation cascade, mitochondrial fractionation, single lab","pmids":["35964866"],"is_preprint":false}],"current_model":"RIPK3 (RIP3) is a serine/threonine kinase that acts as the central hub of the necrosome: upon death receptor, TLR, or innate sensor (ZBP1/DAI) activation, RIPK3 assembles with RIPK1 via RHIM-domain-driven amyloid-like oligomerization into mosaic rod-shaped necrosomes, undergoes autophosphorylation (promoted by kinase-domain homodimerization), and phosphorylates MLKL at T224/S227 to drive its oligomerization, membrane translocation, and necroptotic cell death; beyond necroptosis, RIPK3 can also activate CaMKII (mediating mPTP opening in cardiac cells), promote NLRP3 inflammasome activation, drive NF-κB/Erk/IFN-β inflammatory signaling as a scaffold independently of its kinase activity, and phosphorylate FSP1 to promote ferroptosis, while its activity and stability are tightly regulated by multiple E3 ligases (PELI1, TRIM25, MG53) that mediate K48-ubiquitin-dependent proteasomal degradation, by inhibitory phosphorylation at S164/T165, and by caspase-8-mediated cleavage (which restrains NLRP3 but is dispensable for blocking necroptosis)."},"narrative":{"mechanistic_narrative":"RIPK3 is a serine/threonine kinase that functions as the executioner hub of programmed necrosis (necroptosis) while also serving as a death-independent scaffold for inflammatory and metabolic signaling [PMID:20413098, PMID:21804564, PMID:28366204]. It was first identified as a RIP1-binding kinase recruited to the TNFR1 complex [PMID:10358032], and is now understood to assemble with RIPK1 through RHIM-dependent oligomerization into mosaic rod-shaped necrosomes in which alternating RIPK1 and RIPK3 oligomeric domains form; RIPK3 homo-oligomers of tetramer size or above provide the platform for downstream effector recruitment [PMID:35256774]. Kinase-domain homodimerization through a RAF-like interface drives cis-autophosphorylation, and phosphorylation of a single RIPK3 molecule within a dimer is sufficient to license effector engagement [PMID:24902902, PMID:30131368]. Activating C-lobe phosphorylation at T224/S227 mediates stable recruitment of MLKL — an essential checkpoint preceding MLKL phosphorylation — which then disengages from RIPK3 via a pseudokinase-domain conformational transition to execute membrane permeabilization, while activation-loop phosphorylation at S164/T165 negatively regulates kinase activity [PMID:35739084, PMID:33850121]. Beyond MLKL, RIPK3 phosphorylates additional substrates to drive distinct death and signaling outcomes: CaMKII to open the mitochondrial permeability transition pore in cardiac necroptosis [PMID:26726877], and FSP1 to promote ferroptosis downstream of ZBP1-sensed mitochondrial Z-DNA [PMID:38493248]. RIPK3 nucleation can be spatially organized by an OASL liquid-liquid phase-separated platform during viral infection that facilitates its amyloid-like fibrillation and autophosphorylation [PMID:36604592]. Independently of its kinase activity and of MLKL, RIPK3 acts as a scaffold to drive Erk/cFos/NF-κB and IFN-β inflammatory programs, NLRP3 inflammasome activation, and ubiquitin-dependent cytokine production, and restricts viral pathogenesis through immunometabolic routes such as IRG1/itaconate induction [PMID:27396959, PMID:28461567, PMID:25693118, PMID:36268590, PMID:30635240, PMID:28366204]. RIPK3 abundance and activity are tightly restrained by multiple K48-ubiquitin E3 ligases that target it for proteasomal degradation — PELI1 (via T182 phosphorylation–dependent recognition and K363 ubiquitination), TRIM25 (K501), and MG53 — by PRMT1-mediated arginine methylation that blocks the RIP1-RIP3 interaction, and by caspase-8 cleavage at D333, which restrains NLRP3 activation but is dispensable for blocking necroptosis [PMID:29883609, PMID:33953350, PMID:37527538, PMID:37005412, PMID:38514849].","teleology":[{"year":1999,"claim":"Established RIPK3's foundational identity as a RIP1-binding kinase, defining the physical link that would later prove central to necrosome assembly.","evidence":"Co-IP, overexpression, and NF-κB reporter assays mapping RIP3-RIP1 binding via the unique C-terminus at the TNFR1 complex","pmids":["10358032"],"confidence":"Medium","gaps":["Did not identify necroptosis as RIPK3's function","MLKL and downstream effectors not yet known","Overexpression-induced apoptosis phenotype not mechanistically resolved"]},{"year":2010,"claim":"Defined RIPK3 as an in vivo driver of virus-associated necrosis and showed this death can proceed independently of RIP1, broadening RIPK3 beyond canonical TNF necroptosis.","evidence":"RIP3-deficient mice in MCMV infection with viral vIRA inhibitor mapping to RIP3-RIP1 RHIM interactions","pmids":["20413098"],"confidence":"High","gaps":["MLKL not yet identified as effector","Molecular trigger of RIP1-independent death unresolved"]},{"year":2011,"claim":"Demonstrated via clean genetic epistasis that RIPK3-dependent necrosis drives tissue inflammation when apoptotic (FADD) signaling is removed, establishing physiological relevance.","evidence":"FADD IEC-KO × RIP3 KO double-knockout mice with intestinal histopathology","pmids":["21804564"],"confidence":"High","gaps":["Did not resolve the molecular execution step downstream of RIPK3","Relationship to caspase-8 restraint not yet detailed"]},{"year":2012,"claim":"Probed the breadth of RIPK3 kinase output, indicating substrates beyond direct necroptotic effectors and a candidate phosphorylation motif.","evidence":"SILAC quantitative phosphoproteomics comparing RIP3+/+ vs RIP3−/− macrophages and MEFs","pmids":["22942356"],"confidence":"Medium","gaps":["Specific physiological substrates not individually validated","Direct vs indirect phosphorylation not distinguished"]},{"year":2013,"claim":"Identified activating (RIPK3 S204) and inhibitory (RIPK1 S89) phosphosites, beginning the dissection of phospho-regulation governing necrosis initiation.","evidence":"Site-directed mutagenesis with phosphomimetics, kinase activity and cell death assays","pmids":["24059293"],"confidence":"Medium","gaps":["Endogenous kinase responsible for S204 phosphorylation not defined","Structural basis of activation not addressed"]},{"year":2014,"claim":"Resolved the activation mechanism: RIPK3 homo-dimerization/oligomerization drives autophosphorylation sufficient for MLKL recruitment, while RIPK1 both activates and restrains RIPK3 and caspase-8 controls dimer propagation.","evidence":"Chemical-inducible FKBP/rapamycin dimerization systems, RIPK1 KO cells, phosphorylation and cell-death readouts (two studies)","pmids":["24902902","24902904"],"confidence":"High","gaps":["Structural interface of dimerization not yet defined","Mechanism of caspase-8 control of dimer stability unresolved"]},{"year":2014,"claim":"Distinguished RIPK3's catalytic from scaffold/allosteric functions, showing kinase-dead D161N forces a RIP3-FADD-caspase-8-cFLIP apoptotic complex while K51A does not, explaining divergent mouse lethality.","evidence":"Selective RIP3 kinase inhibitors, kinase-dead and RHIM mutants, complex Co-IP, knock-in mice","pmids":["25459880"],"confidence":"High","gaps":["Allosteric basis of D161N gain-of-function not yet structurally explained (addressed later)","How inhibitors flip output to apoptosis at high dose incompletely defined"]},{"year":2015,"claim":"Separated kinase-dependent from kinase-independent RIPK3 control of NLRP3 inflammasome activation, contingent on IAP and caspase-8 status.","evidence":"IAP-, caspase-8-, MLKL-, RIPK3-KO combinations with LPS, inflammasome assays, in vivo arthritis","pmids":["25693118"],"confidence":"High","gaps":["Direct RIPK3 scaffold partners for inflammasome assembly not fully mapped","Role of RIPK3/MLKL ubiquitylation mechanistically incomplete"]},{"year":2016,"claim":"Uncovered RIPK3 death-independent inflammatory signaling, driving Erk/cFos/NF-κB and CaMKII-mPTP cardiac necroptosis via non-MLKL substrate routes.","evidence":"Kinase inhibitors, RIP3 KO mice, LPS macrophage stimulation, cardiac I/R and doxorubicin models, CaMKII Co-IP and phosphorylation assays","pmids":["27396959","26726877"],"confidence":"Medium","gaps":["Direct vs indirect CaMKII phosphorylation not fully resolved","Scaffold partners for Erk/NF-κB activation not enumerated"]},{"year":2017,"claim":"Demonstrated death-independent neuroinflammatory and IFN-β signaling roles of RIPK3, where MLKL is dispensable but necrosome-like aggregates support TRIF signaling.","evidence":"Ripk3−/− vs Mlkl−/− mice in WNV infection, chemokine/flow cytometry; macrophage IFN-β assays","pmids":["28366204","28461567"],"confidence":"High","gaps":["Molecular composition of signaling-competent aggregates not defined","Transcriptional targets driving chemokine output not mapped"]},{"year":2018,"claim":"Resolved the structural basis of RIPK3 activation and a dedicated degradative brake, linking kinase-domain dimerization to cis-autophosphorylation and PELI1-mediated K48 degradation of active RIPK3.","evidence":"Structural analysis with dimer-interface mutagenesis and knock-in mice; Co-IP, in vitro ubiquitination and kinase assays mapping T182/K363","pmids":["30131368","29883609"],"confidence":"High","gaps":["Full set of physiological E3 ligases not yet enumerated (extended later)","Quantitative kinetics of dimerization-coupled autophosphorylation not defined"]},{"year":2018,"claim":"Extended RIPK3 into non-necroptotic metabolic and immunomodulatory disease pathways, acting through AKT-ACL in fibrosis and ROS/caspase-1/PPARγ in tumor macrophage polarization.","evidence":"RIPK3 KO vs MLKL KO fibrosis models, TGF-β1 fibroblast assays; RIPK3 KO TAMs with PPARγ cleavage and polarization readouts","pmids":["29415885","32122992"],"confidence":"Medium","gaps":["Direct RIPK3 substrates in these axes not identified","Whether RIPK3 acts catalytically or as scaffold in fibrosis not resolved"]},{"year":2019,"claim":"Established RIPK3 as an immunometabolic antiviral effector via the ZBP1-IRG1-itaconate axis and identified CK1γ as a necrosome-associated RIPK3 kinase.","evidence":"ZBP1/RIPK3 KO mice in Zika infection with metabolomics; gain-of-function kinase screen plus in vitro kinase assays for CK1γ","pmids":["30635240","31801942"],"confidence":"Medium","gaps":["RIPK3 substrate driving IRG1 induction not defined","Functional consequence of CK1γ-mediated RIPK3 phosphorylation incompletely mapped"]},{"year":2020,"claim":"Expanded the degradative control of RIPK3 stability through TRIM25-mediated K48 ubiquitination at K501 and proteasome-coupled fate decisions.","evidence":"Co-IP, ubiquitination assays, TRIM25 KO cells, K501R mutagenesis; proteasome inhibitor studies with K264R mutants","pmids":["33953350","26786097"],"confidence":"Medium","gaps":["No in vitro reconstitution of TRIM25-RIPK3 ubiquitination","Hierarchy among PELI1/TRIM25 ubiquitination events unresolved"]},{"year":2021,"claim":"Defined viral and host strategies controlling RIPK3 — orthopoxvirus vIRD hijacks SCF to degrade RIPK3, while ZBP1 uses RIPK1/RIPK3 as scaffolds for cIAP1/LUBAC-driven ubiquitin signaling independent of kinase activity.","evidence":"siRNA screen, Co-IP, ubiquitination assays, RIPK3/MLKL KO mice for vIRD; ubiquitin chain-type analysis and cytokine assays in HT29 cells for ZBP1","pmids":["33444549","36268590"],"confidence":"High","gaps":["Endogenous counterpart of vIRD-targeted degradation pathway not fully defined","Scaffolding stoichiometry within the ZBP1 complex unresolved"]},{"year":2022,"claim":"Refined the activation code and supramolecular architecture: T224/S227 govern stable MLKL recruitment, S164/T165 inhibit kinase activity, MLKL disengages via conformational change, and necrosomes are mosaic rod-shaped RIP1/RIP3 oligomer assemblies; caspase-8 cleavage at D333 restrains NLRP3 but not necroptosis.","evidence":"Phosphoproteomics and systematic phosphosite mutagenesis in HT29; MLKL crystal structures with monobodies; super-resolution STORM/PALM imaging; Ripk3 D333A knock-in mice","pmids":["35739084","33850121","35256774","38514849"],"confidence":"High","gaps":["Kinase responsible for inhibitory S164/T165 not assigned","Trigger for MLKL disengagement timing not fully defined"]},{"year":2022,"claim":"Linked RIPK3 to mitochondrial and lipid metabolic remodeling in liver and kidney disease, partly through RIPK3-MLKL-CaMKII-Smad2/3 fibrotic signaling and effects on mitochondrial biogenesis and lipid droplets.","evidence":"Ripk3−/− mice (NAFLD/CDAA), CRISPR hepatocytes, proteomics, LD imaging; mitochondrial fractionation and CaMKII/Smad2/3 assays in UUO","pmids":["36029129","35964866"],"confidence":"Medium","gaps":["Whether metabolic effects are catalytic or scaffold-dependent unresolved","Direct molecular target initiating mitochondrial translocation not defined"]},{"year":2023,"claim":"Identified spatial and post-translational regulators of RIPK3 nucleation: OASL phase condensation scaffolds RIPK3 fibrillation, PRMT1 arginine methylation (R486) blocks the RIP1-RIP3 interaction, and MG53/p55γ mediate proteasomal degradation in cardiac protection.","evidence":"Phase condensation and fibril assays with Oasl1 KO mice; in vitro methylation and Co-IP for PRMT1; Co-IP/MS, ChIP and transgenic mice for p55γ-MG53 axis","pmids":["36604592","37005412","37527538"],"confidence":"High","gaps":["Interplay between methylation and degradation control not integrated","How OASL condensates are dissolved/regulated unknown"]},{"year":2024,"claim":"Established RIPK3 as a dual death-pathway effector, phosphorylating FSP1 to promote ferroptosis alongside MLKL-driven necroptosis, and driving MLKL-PGAM5-Drp1 mitochondrial fission in diabetic kidney disease.","evidence":"Endothelial-specific Zbp1/Ripk3 KO mice with FSP1 phosphorylation/activity assays; Ripk3 KO DKD model with PGAM5/Drp1 phosphorylation and mitochondrial imaging","pmids":["38493248","39089491"],"confidence":"Medium","gaps":["FSP1 phosphosite(s) not precisely mapped","Determinants selecting necroptosis vs ferroptosis output not defined"]},{"year":null,"claim":"How RIPK3 selects among its diverse outputs — necroptosis, ferroptosis, CaMKII/mPTP death, and kinase-independent inflammatory scaffolding — at a single molecular hub remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking substrate choice to upstream stimulus or complex composition","Quantitative rules governing scaffold vs catalytic mode not established","Integration of competing E3 ligases and methylation in setting RIPK3 levels not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,9,16,24,32]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[5,16,24,32]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[11,13,21]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[11]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,25]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[9,33,35]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,2,5,24,32]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,11,12,13,18,21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,13,28]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[14,20,27,30,31]}],"complexes":["necrosome (RIPK1-RIPK3-MLKL)","RIP3-FADD-caspase-8-cFLIP complex","ZBP1-RIPK1-RIPK3-cIAP1-LUBAC complex"],"partners":["RIPK1","MLKL","ZBP1","PELI1","TRIM25","CAMKII","FSP1","OASL"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y572","full_name":"Receptor-interacting serine/threonine-protein kinase 3","aliases":["RIP-like protein kinase 3","Receptor-interacting protein 3","RIP-3"],"length_aa":518,"mass_kda":56.9,"function":"Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609, PubMed:32657447). Necroptosis, a programmed cell death process in response to death-inducing TNF family members, is triggered by RIPK3 following activation by ZBP1 (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609, PubMed:32298652). Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:25316792, PubMed:29883609). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Also regulates apoptosis: apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (By similarity). Phosphorylates RIPK1: RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (PubMed:19524513). In some cell types, also able to restrict viral replication by promoting cell death-independent responses (By similarity). In response to Zika virus infection in neurons, promotes a cell death-independent pathway that restricts viral replication: together with ZBP1, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (By similarity). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (By similarity). RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL (PubMed:19498109). These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production (PubMed:19498109) (Microbial infection) In case of herpes simplex virus 1/HHV-1 infection, forms heteromeric amyloid structures with HHV-1 protein RIR1/ICP6 which may inhibit RIPK3-mediated necroptosis, thereby preventing host cell death pathway and allowing viral evasion","subcellular_location":"Cytoplasm, cytosol; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y572/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RIPK3","classification":"Not Classified","n_dependent_lines":67,"n_total_lines":1208,"dependency_fraction":0.055463576158940396},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RIPK3","total_profiled":1310},"omim":[{"mim_id":"620886","title":"tRNA METHYLTRANSFERASE 6, NONCATALYTIC SUBUNIT; TRMT6","url":"https://www.omim.org/entry/620886"},{"mim_id":"620885","title":"tRNA METHYLTRANSFERASE 61A; TRMT61A","url":"https://www.omim.org/entry/620885"},{"mim_id":"619611","title":"INTERSTITIAL LUNG DISEASE 1; ILD1","url":"https://www.omim.org/entry/619611"},{"mim_id":"615712","title":"OTU DEUBIQUITINASE WITH LINEAR LINKAGE SPECIFICITY; OTULIN","url":"https://www.omim.org/entry/615712"},{"mim_id":"615153","title":"MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN; MLKL","url":"https://www.omim.org/entry/615153"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RIPK3"},"hgnc":{"alias_symbol":["RIP3"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y572","domains":[{"cath_id":"3.30.200.20","chopping":"19-97","consensus_level":"high","plddt":90.4985,"start":19,"end":97},{"cath_id":"1.10.510.10","chopping":"102-168_183-298","consensus_level":"high","plddt":92.6331,"start":102,"end":298}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y572","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y572-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y572-F1-predicted_aligned_error_v6.png","plddt_mean":67.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RIPK3","jax_strain_url":"https://www.jax.org/strain/search?query=RIPK3"},"sequence":{"accession":"Q9Y572","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y572.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y572/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y572"}},"corpus_meta":[{"pmid":"26726877","id":"PMC_26726877","title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.","date":"2016","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26726877","citation_count":676,"is_preprint":false},{"pmid":"25693118","id":"PMC_25693118","title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25693118","citation_count":575,"is_preprint":false},{"pmid":"25459880","id":"PMC_25459880","title":"RIP3 induces apoptosis independent of pronecrotic kinase activity.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25459880","citation_count":539,"is_preprint":false},{"pmid":"21804564","id":"PMC_21804564","title":"FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21804564","citation_count":516,"is_preprint":false},{"pmid":"20413098","id":"PMC_20413098","title":"Virus inhibition of RIP3-dependent necrosis.","date":"2010","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/20413098","citation_count":477,"is_preprint":false},{"pmid":"20354226","id":"PMC_20354226","title":"The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.","date":"2010","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20354226","citation_count":381,"is_preprint":false},{"pmid":"25662614","id":"PMC_25662614","title":"RIPK1 and RIPK3: critical regulators of inflammation and cell death.","date":"2015","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25662614","citation_count":304,"is_preprint":false},{"pmid":"23913919","id":"PMC_23913919","title":"RIP3: a molecular switch for necrosis and inflammation.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23913919","citation_count":292,"is_preprint":false},{"pmid":"30635240","id":"PMC_30635240","title":"The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30635240","citation_count":261,"is_preprint":false},{"pmid":"24902902","id":"PMC_24902902","title":"Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24902902","citation_count":255,"is_preprint":false},{"pmid":"27396959","id":"PMC_27396959","title":"RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27396959","citation_count":245,"is_preprint":false},{"pmid":"24902904","id":"PMC_24902904","title":"RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24902904","citation_count":245,"is_preprint":false},{"pmid":"26817517","id":"PMC_26817517","title":"Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26817517","citation_count":230,"is_preprint":false},{"pmid":"32122992","id":"PMC_32122992","title":"RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis.","date":"2020","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/32122992","citation_count":226,"is_preprint":false},{"pmid":"10358032","id":"PMC_10358032","title":"RIP3, a novel apoptosis-inducing kinase.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10358032","citation_count":202,"is_preprint":false},{"pmid":"28126382","id":"PMC_28126382","title":"Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.","date":"2017","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28126382","citation_count":160,"is_preprint":false},{"pmid":"28366204","id":"PMC_28366204","title":"RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28366204","citation_count":156,"is_preprint":false},{"pmid":"36224345","id":"PMC_36224345","title":"Roles of RIPK3 in necroptosis, cell signaling, and disease.","date":"2022","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36224345","citation_count":152,"is_preprint":false},{"pmid":"31198981","id":"PMC_31198981","title":"RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).","date":"2019","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31198981","citation_count":150,"is_preprint":false},{"pmid":"32035657","id":"PMC_32035657","title":"Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs.","date":"2020","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32035657","citation_count":144,"is_preprint":false},{"pmid":"24902899","id":"PMC_24902899","title":"RIPK1- and RIPK3-induced cell death mode is determined by target availability.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24902899","citation_count":130,"is_preprint":false},{"pmid":"24059293","id":"PMC_24059293","title":"Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24059293","citation_count":118,"is_preprint":false},{"pmid":"30012671","id":"PMC_30012671","title":"A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30012671","citation_count":104,"is_preprint":false},{"pmid":"28462521","id":"PMC_28462521","title":"RIPK3 in cell death and inflammation: the good, the bad, and the ugly.","date":"2017","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/28462521","citation_count":103,"is_preprint":false},{"pmid":"29415885","id":"PMC_29415885","title":"RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29415885","citation_count":102,"is_preprint":false},{"pmid":"35256774","id":"PMC_35256774","title":"Mosaic composition of RIP1-RIP3 signalling hub and its role in regulating cell death.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35256774","citation_count":95,"is_preprint":false},{"pmid":"29883609","id":"PMC_29883609","title":"PELI1 Selectively Targets Kinase-Active RIP3 for Ubiquitylation-Dependent Proteasomal Degradation.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29883609","citation_count":94,"is_preprint":false},{"pmid":"26283397","id":"PMC_26283397","title":"RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26283397","citation_count":94,"is_preprint":false},{"pmid":"33850121","id":"PMC_33850121","title":"Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33850121","citation_count":89,"is_preprint":false},{"pmid":"27323669","id":"PMC_27323669","title":"The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27323669","citation_count":84,"is_preprint":false},{"pmid":"33444549","id":"PMC_33444549","title":"A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33444549","citation_count":83,"is_preprint":false},{"pmid":"33836603","id":"PMC_33836603","title":"A specific RIP3+ subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33836603","citation_count":81,"is_preprint":false},{"pmid":"28069136","id":"PMC_28069136","title":"The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.","date":"2016","source":"International review of cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28069136","citation_count":81,"is_preprint":false},{"pmid":"38684668","id":"PMC_38684668","title":"RIPK3 signaling and its role in regulated cell death and diseases.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38684668","citation_count":79,"is_preprint":false},{"pmid":"28844856","id":"PMC_28844856","title":"RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells.","date":"2017","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/28844856","citation_count":76,"is_preprint":false},{"pmid":"36268590","id":"PMC_36268590","title":"Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/36268590","citation_count":74,"is_preprint":false},{"pmid":"30157175","id":"PMC_30157175","title":"BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.","date":"2018","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/30157175","citation_count":74,"is_preprint":false},{"pmid":"32895234","id":"PMC_32895234","title":"TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis.","date":"2020","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32895234","citation_count":73,"is_preprint":false},{"pmid":"28579326","id":"PMC_28579326","title":"RIP1-RIP3-DRP1 pathway regulates NLRP3 inflammasome activation following subarachnoid hemorrhage.","date":"2017","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28579326","citation_count":69,"is_preprint":false},{"pmid":"24556404","id":"PMC_24556404","title":"More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling.","date":"2013","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24556404","citation_count":68,"is_preprint":false},{"pmid":"32144343","id":"PMC_32144343","title":"Bisphenol A induces coronary endothelial cell necroptosis by activating RIP3/CamKII dependent pathway.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32144343","citation_count":65,"is_preprint":false},{"pmid":"22942356","id":"PMC_22942356","title":"Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics.","date":"2012","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22942356","citation_count":64,"is_preprint":false},{"pmid":"30975711","id":"PMC_30975711","title":"Necroptosis mediators RIPK3 and MLKL suppress intracellular Listeria replication independently of host cell killing.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30975711","citation_count":63,"is_preprint":false},{"pmid":"26786097","id":"PMC_26786097","title":"Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26786097","citation_count":60,"is_preprint":false},{"pmid":"32771377","id":"PMC_32771377","title":"RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease.","date":"2020","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32771377","citation_count":59,"is_preprint":false},{"pmid":"33589776","id":"PMC_33589776","title":"A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/33589776","citation_count":59,"is_preprint":false},{"pmid":"30237400","id":"PMC_30237400","title":"HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis.","date":"2018","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30237400","citation_count":57,"is_preprint":false},{"pmid":"35064213","id":"PMC_35064213","title":"Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3/MLKL to prevent lymphopenia.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35064213","citation_count":56,"is_preprint":false},{"pmid":"38493248","id":"PMC_38493248","title":"Sensing of mitochondrial DNA by ZBP1 promotes RIPK3-mediated necroptosis and ferroptosis in response to diquat poisoning.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/38493248","citation_count":54,"is_preprint":false},{"pmid":"27377128","id":"PMC_27377128","title":"RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27377128","citation_count":54,"is_preprint":false},{"pmid":"34654937","id":"PMC_34654937","title":"RIPK3 signaling and its role in the pathogenesis of cancers.","date":"2021","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/34654937","citation_count":53,"is_preprint":false},{"pmid":"28461567","id":"PMC_28461567","title":"Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28461567","citation_count":53,"is_preprint":false},{"pmid":"28462524","id":"PMC_28462524","title":"RIPK3-driven cell death during virus infections.","date":"2017","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/28462524","citation_count":52,"is_preprint":false},{"pmid":"31819256","id":"PMC_31819256","title":"Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31819256","citation_count":52,"is_preprint":false},{"pmid":"31988496","id":"PMC_31988496","title":"RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/31988496","citation_count":48,"is_preprint":false},{"pmid":"33953350","id":"PMC_33953350","title":"E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/33953350","citation_count":48,"is_preprint":false},{"pmid":"27158445","id":"PMC_27158445","title":"Post-translational control of RIPK3 and MLKL mediated necroptotic cell death.","date":"2015","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/27158445","citation_count":45,"is_preprint":false},{"pmid":"36029129","id":"PMC_36029129","title":"RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease.","date":"2022","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/36029129","citation_count":43,"is_preprint":false},{"pmid":"34710282","id":"PMC_34710282","title":"Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis.","date":"2021","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/34710282","citation_count":43,"is_preprint":false},{"pmid":"27974745","id":"PMC_27974745","title":"Mechanisms of RIPK3-induced inflammation.","date":"2016","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27974745","citation_count":38,"is_preprint":false},{"pmid":"36604592","id":"PMC_36604592","title":"OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis.","date":"2023","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36604592","citation_count":38,"is_preprint":false},{"pmid":"36696505","id":"PMC_36696505","title":"RIPK1 blocks T cell senescence mediated by RIPK3 and caspase-8.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36696505","citation_count":38,"is_preprint":false},{"pmid":"33142926","id":"PMC_33142926","title":"The Role of RIPK1 and RIPK3 in Cardiovascular Disease.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33142926","citation_count":37,"is_preprint":false},{"pmid":"35101798","id":"PMC_35101798","title":"Inactivation of RIP3 kinase sensitizes to 15LOX/PEBP1-mediated ferroptotic death.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35101798","citation_count":37,"is_preprint":false},{"pmid":"33625952","id":"PMC_33625952","title":"RIPK3 Activates MLKL-mediated Necroptosis and Inflammasome Signaling during Streptococcus Infection.","date":"2021","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33625952","citation_count":37,"is_preprint":false},{"pmid":"37475188","id":"PMC_37475188","title":"RIPK3-MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis.","date":"2023","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37475188","citation_count":36,"is_preprint":false},{"pmid":"30131368","id":"PMC_30131368","title":"Kinase domain dimerization drives RIPK3-dependent necroptosis.","date":"2018","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/30131368","citation_count":36,"is_preprint":false},{"pmid":"36166972","id":"PMC_36166972","title":"RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.","date":"2022","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36166972","citation_count":36,"is_preprint":false},{"pmid":"25858093","id":"PMC_25858093","title":"The serine threonine kinase RIP3: lost and found.","date":"2015","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/25858093","citation_count":35,"is_preprint":false},{"pmid":"35046131","id":"PMC_35046131","title":"Bone Marrow-Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury.","date":"2022","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/35046131","citation_count":35,"is_preprint":false},{"pmid":"36240069","id":"PMC_36240069","title":"Mechanisms of TNF-independent RIPK3-mediated cell death.","date":"2022","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/36240069","citation_count":34,"is_preprint":false},{"pmid":"33247805","id":"PMC_33247805","title":"RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage.","date":"2020","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33247805","citation_count":34,"is_preprint":false},{"pmid":"27308332","id":"PMC_27308332","title":"Execution of RIPK3-regulated necrosis.","date":"2014","source":"Molecular & cellular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27308332","citation_count":33,"is_preprint":false},{"pmid":"31801942","id":"PMC_31801942","title":"Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31801942","citation_count":31,"is_preprint":false},{"pmid":"37005412","id":"PMC_37005412","title":"PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37005412","citation_count":29,"is_preprint":false},{"pmid":"37366309","id":"PMC_37366309","title":"Inhibition of gingival fibroblast necroptosis mediated by RIPK3/MLKL attenuates periodontitis.","date":"2023","source":"Journal of clinical periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/37366309","citation_count":28,"is_preprint":false},{"pmid":"35739084","id":"PMC_35739084","title":"Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35739084","citation_count":27,"is_preprint":false},{"pmid":"31848291","id":"PMC_31848291","title":"RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.","date":"2019","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/31848291","citation_count":27,"is_preprint":false},{"pmid":"39089491","id":"PMC_39089491","title":"RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling.","date":"2024","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/39089491","citation_count":26,"is_preprint":false},{"pmid":"33526566","id":"PMC_33526566","title":"RIPK3 Facilitates Host Resistance to Oral Toxoplasma gondii Infection.","date":"2021","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33526566","citation_count":26,"is_preprint":false},{"pmid":"32613000","id":"PMC_32613000","title":"RIPK3: A New Player in Renal Fibrosis.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32613000","citation_count":25,"is_preprint":false},{"pmid":"30755477","id":"PMC_30755477","title":"Inflammation, necrosis, and the kinase RIP3 are key mediators of AAG-dependent alkylation-induced retinal degeneration.","date":"2019","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/30755477","citation_count":25,"is_preprint":false},{"pmid":"31953345","id":"PMC_31953345","title":"Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis.","date":"2020","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31953345","citation_count":24,"is_preprint":false},{"pmid":"35964866","id":"PMC_35964866","title":"RIPK3-MLKL signaling activates mitochondrial CaMKII and drives intrarenal extracellular matrix production during CKD.","date":"2022","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35964866","citation_count":24,"is_preprint":false},{"pmid":"37204757","id":"PMC_37204757","title":"Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis.","date":"2023","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/37204757","citation_count":24,"is_preprint":false},{"pmid":"38514849","id":"PMC_38514849","title":"RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/38514849","citation_count":23,"is_preprint":false},{"pmid":"33513913","id":"PMC_33513913","title":"RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33513913","citation_count":23,"is_preprint":false},{"pmid":"27984090","id":"PMC_27984090","title":"RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death.","date":"2016","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27984090","citation_count":23,"is_preprint":false},{"pmid":"37248964","id":"PMC_37248964","title":"Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis.","date":"2023","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37248964","citation_count":23,"is_preprint":false},{"pmid":"32796025","id":"PMC_32796025","title":"RIPK3-MLKL-Mediated Neutrophil Death Requires Concurrent Activation of Fibroblast Activation Protein-α.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32796025","citation_count":23,"is_preprint":false},{"pmid":"39870301","id":"PMC_39870301","title":"CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway.","date":"2025","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/39870301","citation_count":22,"is_preprint":false},{"pmid":"34572045","id":"PMC_34572045","title":"MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34572045","citation_count":22,"is_preprint":false},{"pmid":"33221042","id":"PMC_33221042","title":"Enhanced RIPK3 kinase activity-dependent lytic cell death in M1 but not M2 macrophages.","date":"2020","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33221042","citation_count":22,"is_preprint":false},{"pmid":"38630819","id":"PMC_38630819","title":"RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/38630819","citation_count":21,"is_preprint":false},{"pmid":"38503474","id":"PMC_38503474","title":"Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery.","date":"2024","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38503474","citation_count":21,"is_preprint":false},{"pmid":"37527538","id":"PMC_37527538","title":"p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.","date":"2023","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/37527538","citation_count":21,"is_preprint":false},{"pmid":"36121858","id":"PMC_36121858","title":"RIPK3 and caspase 8 collaborate to limit herpes simplex encephalitis.","date":"2022","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/36121858","citation_count":21,"is_preprint":false},{"pmid":"29238045","id":"PMC_29238045","title":"RIPK3 promotes adenovirus type 5 activity.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29238045","citation_count":21,"is_preprint":false},{"pmid":"39044278","id":"PMC_39044278","title":"Influenza virus infection activates TAK1 to suppress RIPK3-independent apoptosis and RIPK1-dependent necroptosis.","date":"2024","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/39044278","citation_count":20,"is_preprint":false},{"pmid":"36030035","id":"PMC_36030035","title":"RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity.","date":"2022","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/36030035","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49851,"output_tokens":9517,"usd":0.146154,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19613,"output_tokens":6829,"usd":0.134395,"stage2_stop_reason":"end_turn"},"total_usd":0.280549,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"RIP3 (RIPK3) is a novel kinase containing an N-terminal kinase domain homologous to RIP and RIP2, but with a unique C-terminus. RIP3 binds RIP1 through its unique C-terminal segment, is recruited to the TNF receptor-1 signaling complex, and attenuates RIP1- and TNFR1-induced NF-κB activation. Overexpression induces apoptosis via selective binding to large prodomain initiator caspases.\",\n      \"method\": \"Co-immunoprecipitation, overexpression, NF-κB reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding assays and functional NF-κB reporter, single lab, foundational characterization paper\",\n      \"pmids\": [\"10358032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Murine cytomegalovirus (MCMV) infection induces RIP3-dependent necrosis. RIP3 kinase activity and RHIM-dependent interactions control virus-associated necrosis; this death proceeds independently of RIP1, distinguishing it from TNFα-induced necroptosis. The viral M45-encoded inhibitor vIRA targets RIP3 and disrupts RIP3-RIP1 interactions, suppressing both TNF-induced and virus-induced necroptosis.\",\n      \"method\": \"Genetic knockout (RIP3-deficient mice), viral infection models, co-immunoprecipitation, in vivo attenuation studies\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined phenotype, mechanistic interaction studies, in vivo validation, replicated across infection contexts\",\n      \"pmids\": [\"20413098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genetic deficiency of RIP3 (RIPK3) prevents spontaneous epithelial cell necrosis, Paneth cell loss, and colitis in FADD-deficient intestinal epithelial cell-specific knockout mice, demonstrating that RIP3-dependent programmed necrosis drives intestinal inflammation when FADD-mediated apoptotic signaling is absent.\",\n      \"method\": \"Genetic epistasis (double-knockout mice: FADD IEC-KO × RIP3 KO), histopathology\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis in vivo with defined phenotypic readout, published in high-impact journal\",\n      \"pmids\": [\"21804564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Quantitative phosphoproteomic analysis (SILAC) comparing RIP3+/+ and RIP3−/− cells identified a potential RIP3 phosphorylation motif and a broad set of RIP3-regulated phosphoproteins spanning cell cycle, metabolism, and development, suggesting RIP3 kinase activity controls phosphorylation of substrates beyond direct necroptotic effectors.\",\n      \"method\": \"Quantitative phosphoproteomics (SILAC + IMAC-HILIC + nanoLC-MS/MS) in macrophages and MEFs\",\n      \"journal\": \"Molecular & cellular proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic phosphoproteomic screen with KO control, single lab, identifies substrate motif and broad substrate set\",\n      \"pmids\": [\"22942356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phosphorylation of RIP3 at S204 creates a phosphomimetic (S204D) that drives programmed necrosis independently of RIP1 and necrostatin-1. Mutation of RIP1 S89 to alanine enhances RIP1 kinase activity and necrosis without affecting necrosome formation, identifying S89 as an inhibitory phosphosite on RIP1 upstream of RIP3.\",\n      \"method\": \"Site-directed mutagenesis, cell death assays, siRNA knockdown, kinase activity assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"24059293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RIP3 dimerization leads to RIP3 intramolecular autophosphorylation; phosphorylation of one RIP3 molecule within a dimer is sufficient for MLKL recruitment and necroptosis induction. RIP1-RIP3 heterodimers alone cannot trigger necroptosis without recruitment of additional RIP3; RIP3-RIP3 homo-interaction is the critical event for necroptosis execution.\",\n      \"method\": \"Inducible dimerization systems (chemical-inducible FKBP/rapamycin), phosphorylation assays, MLKL recruitment assays, cell death assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with inducible dimerization, mutagenesis, multiple orthogonal readouts in one study\",\n      \"pmids\": [\"24902902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RIPK1 both activates RIPK3 (via RHIM-dependent oligomerization in response to TNF signaling) and negatively regulates spontaneous RIPK3 oligomerization in the cytosol. Chemically enforced RIPK3 oligomerization triggers necroptosis independent of RHIM domain, TNF, or RIPK1 kinase activity. Caspase-8 controls propagation/stability of RIPK3 dimers seeded by RHIM interactions.\",\n      \"method\": \"Inducible dimerization/oligomerization constructs, RIPK1 KO cells, chemical inhibition of RIPK1, cell death assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with engineered constructs, KO controls, multiple orthogonal methods in one study\",\n      \"pmids\": [\"24902904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Three selective RIP3 kinase inhibitors inhibit necroptosis but, at higher concentrations, induce apoptosis via RHIM-driven recruitment of RIP1 to form a RIP3-FADD-caspase-8-cFLIP complex, independent of pronecrotic kinase activities and MLKL. A kinase-dead D161N RIP3 mutant spontaneously induces apoptosis, while K51A does not — RIP3 D161N/D161N mice die perinatally but RIP3 K51A/K51A mice are viable.\",\n      \"method\": \"Small-molecule inhibitors, kinase-dead mutants, RHIM mutagenesis, caspase-8 complex co-immunoprecipitation, knock-in mice\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple compounds, mutagenesis, knock-in mice, Co-IP of complex, multiple orthogonal methods\",\n      \"pmids\": [\"25459880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In the absence of IAPs, LPS triggers RIPK3 to activate caspase-8 and promote apoptosis and NLRP3-caspase-1 activation independently of RIPK3 kinase activity and MLKL. When both IAPs and caspase-8 are absent, RIPK3 kinase activity and MLKL are required for TLR-induced NLRP3 activation. TRIF and IAPs regulate RIPK3 and MLKL ubiquitylation.\",\n      \"method\": \"Genetic KO models (IAP-deficient, caspase-8 KO, MLKL KO, RIPK3 KO), LPS treatment, inflammasome activation assays, in vivo arthritis model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic KO combinations with defined mechanistic outcomes, in vivo validation, two independent epistasis results\",\n      \"pmids\": [\"25693118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RIP3 triggers myocardial necroptosis through activation of CaMKII (via phosphorylation or oxidation), rather than through RIP1 and MLKL, leading to mitochondrial permeability transition pore (mPTP) opening. RIP3 deficiency or CaMKII inhibition ameliorates ischemia-reperfusion and doxorubicin-induced myocardial necroptosis and heart failure in mice.\",\n      \"method\": \"RIP3 KO mice, CaMKII inhibition (genetic and pharmacologic), cardiac ischemia-reperfusion models, co-immunoprecipitation, phosphorylation assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple in vivo models, KO validation, pharmacologic confirmation, identification of CaMKII as RIP3 substrate\",\n      \"pmids\": [\"26726877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Proteasome inhibitors (MG132, bortezomib) activate RIPK3-MLKL necroptotic pathway in a RHIM-dependent but caspase-inhibition-independent manner. K48-linked ubiquitination of RIPK3 (partially at K264) accumulates upon proteasome inhibition. When MLKL recruitment to RIPK3 is restricted under proteasome inhibition, RIPK3-dependent apoptosis is induced instead.\",\n      \"method\": \"Proteasome inhibitor treatment, RHIM mutagenesis, K264R ubiquitination mutants, cell death assays, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis and pharmacologic dissection, single lab, two orthogonal methods\",\n      \"pmids\": [\"26786097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RIPK1 and RIPK3 kinase activities promote sustained activation of Erk, cFos, and NF-κB to drive pro-inflammatory gene expression in macrophages stimulated by LPS, independently of cell death functions. This regulation requires the adaptor TRIF and proceeds cell-autonomously.\",\n      \"method\": \"Kinase inhibitors, genetic KO, LPS stimulation of primary macrophages, cytokine/signaling assays, in vivo LPS challenge\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacologic tools, defined downstream signaling readouts, in vivo validation, single lab\",\n      \"pmids\": [\"27396959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RIPK3 restricts West Nile virus pathogenesis in the CNS independently of necroptotic cell death: Ripk3−/− mice show enhanced mortality with suppressed neuronal chemokine expression and decreased CNS recruitment of T lymphocytes and inflammatory myeloid cells, while Mlkl−/− mice are unaffected, demonstrating a death-independent neuroinflammatory signaling role for RIPK3.\",\n      \"method\": \"Ripk3−/− and Mlkl−/− mouse models, WNV infection, flow cytometry, chemokine profiling\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dissection using KO for both RIPK3 and MLKL with defined phenotypic readouts, rigorous controls, published in Cell\",\n      \"pmids\": [\"28366204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RIPK1 and RIPK3 kinase activities direct IFN-β synthesis induced by LPS via necrosome-like aggregates that facilitate canonical TRIF-dependent signaling downstream of TLR4, independently of MLKL and necroptosis.\",\n      \"method\": \"Genetic KO and kinase inhibitors, macrophage LPS stimulation, IFN-β ELISA, necrosome formation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacologic dissection, defined downstream signaling endpoint, single lab\",\n      \"pmids\": [\"28461567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PELI1 E3 ubiquitin ligase selectively targets kinase-active RIP3 for degradation: phosphorylation of RIP3 on T182 leads to interaction with the FHA domain of PELI1, which then mediates K48-linked polyubiquitination of RIP3 on K363, promoting proteasomal degradation and preventing cell death from RIP3 hyperactivation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, mutagenesis (T182, K363), in vitro kinase assays, cell death assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of ubiquitination, mutagenesis of key residues, multiple orthogonal methods, mechanistic link between phosphorylation and ubiquitination\",\n      \"pmids\": [\"29883609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RIPK3 promotes kidney fibrosis through AKT-dependent activation of ATP citrate lyase (ACL), independently of MLKL-dependent necroptosis. RIPK3-deficient mice are protected from UUO- and adenine diet-induced fibrosis while MLKL-deficient mice are not. Genetic or chemical RIPK3 inhibition suppresses TGF-β1-induced AKT and ACL phosphorylation in fibroblasts.\",\n      \"method\": \"RIPK3 KO and MLKL KO mouse models, UUO/adenine diet fibrosis models, AKT/ACL phosphorylation assays, fibroblast TGF-β1 stimulation\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis comparing RIPK3 KO vs MLKL KO, in vitro mechanistic pathway, two in vivo models\",\n      \"pmids\": [\"29415885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RIPK3 kinase domain homodimerizes through a surface structurally similar to RAF family members; mutation of the dimer interface residues impairs dimerization and necroptosis. Kinase domain dimerization drives cis-autophosphorylation of RIPK3 and is required for necroptosis. The D161N mutation enhances this noncatalytic allosteric dimerization function, explaining its apoptosis-inducing activity.\",\n      \"method\": \"Structural analysis, dimerization interface mutagenesis, co-immunoprecipitation, cell death assays, RIPK3 D161N heterozygous × RIPK1 KO mice\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural modeling plus mutagenesis of dimerization interface plus genetic mouse models, multiple orthogonal methods\",\n      \"pmids\": [\"30131368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RIPK3 deficiency in TAMs reduces ROS and inhibits caspase-1-mediated cleavage of PPARγ, enabling PPARγ activation and fatty acid oxidation, thus driving M2 polarization and immunosuppression in the tumor microenvironment of hepatocellular carcinoma.\",\n      \"method\": \"RIPK3 KO macrophages, ROS assays, caspase-1 activity assays, PPARγ cleavage assays, macrophage polarization assays\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined molecular readouts, mechanistic pathway dissection, single lab\",\n      \"pmids\": [\"32122992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Neuronal ZBP1 and RIPK3 activation during Zika virus infection restricts viral replication by upregulating the enzyme IRG1 and producing the metabolite itaconate, which inhibits succinate dehydrogenase. This immunometabolic pathway operates independently of necroptotic cell death.\",\n      \"method\": \"ZBP1 KO and RIPK3 KO mouse models, Zika infection, metabolomics, IRG1 expression assays, succinate dehydrogenase activity assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with mechanistic metabolic pathway dissection, multiple orthogonal methods, ZBP1-RIPK3-IRG1-itaconate axis defined\",\n      \"pmids\": [\"30635240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CK1γ1 and CK1γ3 promote TNF-induced necroptosis by forming a complex with the necrosome (RIPK1, RIPK3, MLKL) and phosphorylating RIPK3, affecting its activity. Autophosphorylated CK1γ3 (S344/345) is present in the necrosome. CK1γ is cleaved by caspase-8 during apoptosis, analogous to RIPK1.\",\n      \"method\": \"Gain-of-function kinase screen (546 kinases), Co-IP, in vitro kinase assays with purified proteins, siRNA knockdown, cell death assays, CK1γ inhibitor in vivo\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with purified proteins showing CK1γ phosphorylates RIPK3, plus Co-IP, single lab\",\n      \"pmids\": [\"31801942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TRIM25 E3 ubiquitin ligase directly interacts with RIP3 through its SPRY domain and mediates K48-linked polyubiquitination of RIP3 at K501, promoting proteasomal degradation. The RING domain of TRIM25 is required for this ubiquitination. TRIM25 deficiency inhibits RIP3 ubiquitination and promotes TNF-induced cell necrosis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, TRIM25 KO cells, mutagenesis (K501R), domain-deletion analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, mutagenesis, functional cell death assay; single lab, no in vitro reconstitution\",\n      \"pmids\": [\"33953350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZBP1 induces K63- and M1-linked ubiquitin chains on RIPK1 and ZBP1 itself through cIAP1 and LUBAC, using RIPK1 and RIPK3 as scaffolds (not through their kinase activity) to promote TAK1- and IKK-mediated inflammatory cytokine production, independently of cell death. ZBP1 associates with RIPK1, RIPK3, cIAP1, and LUBAC in HT29 cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin chain-type analysis, kinase inhibitors, caspase inhibitors, cytokine assays in HT29 cells\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP showing complex, ubiquitin chain characterization, kinase-independence demonstrated, single lab\",\n      \"pmids\": [\"36268590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A class of orthopoxvirus proteins (vIRD — viral inducer of RIPK3 degradation) binds host SKP1-Cullin1-F-box (SCF) machinery and RIPK3, triggering ubiquitination and proteasome-mediated degradation of RIPK3 to inhibit necroptosis and regulate virus-induced inflammation.\",\n      \"method\": \"siRNA screen, Co-immunoprecipitation, ubiquitination assays, RIPK3 KO and MLKL KO mice, viral replication assays in vivo\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, ubiquitination assays, genetic KO validation in vivo, mechanism confirmed by rescue in RIPK3/MLKL KO mice\",\n      \"pmids\": [\"33444549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Phosphorylated MLKL disengages from RIPK3 following necroptotic stimulation through a conformational transition of the MLKL pseudokinase domain. Monobody-27 binds MLKL via an epitope overlapping the RIPK3 binding site that is only exposed after pMLKL disengages from RIPK3, identifying MLKL disengagement from RIPK3 as a key regulatory step in necroptosis.\",\n      \"method\": \"Crystal structures of MLKL pseudokinase domain with Monobodies, cell-based necroptosis assays, phospho-MLKL pulldowns\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional cell-based validation, identifies RIPK3-MLKL disengagement as regulatory step\",\n      \"pmids\": [\"33850121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RIPK3 phosphorylation at T224 and S227 (C-lobe) are synergistic, crucial sites for stable interaction with MLKL and promotion of necroptosis in human cells. Activation loop phosphorylation at S164/T165 negatively regulates RIPK3 kinase activity. Stable recruitment of MLKL by phospho-T224/S227 RIPK3 to the necrosome is an essential checkpoint independent of and prior to MLKL phosphorylation.\",\n      \"method\": \"Phosphoproteomics of RIPK3 in HT29 cells, mutagenesis of phosphosites, kinase-inactive RIPK3 controls, cell death assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphoproteomics plus systematic mutagenesis of 21 phosphosites, mechanistic dissection of RIPK3-MLKL interaction, multiple orthogonal methods\",\n      \"pmids\": [\"35739084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Super-resolution microscopy reveals that cellular necrosomes are mosaic structures comprising alternating RIP1 and RIP3 oligomeric domains. Small mosaics are round; large functional mosaics are rod-shaped. RIP3 oligomers of tetramer size or above serve as domains for MLKL oligomerization driven by phospho-RIP3. RIP1 autophosphorylation controls ordered RIP1 oligomerization and is required for RIP1-initiated RIP3 homo-oligomerization in correct configuration for functional rod-shaped mosaic formation.\",\n      \"method\": \"Super-resolution microscopy (STORM/PALM), inducible dimer systems, RIP1 autophosphorylation mutants, MLKL recruitment assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — nanoscale structural imaging combined with functional mutagenesis and reconstitution, multiple orthogonal methods\",\n      \"pmids\": [\"35256774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RIPK3 deficiency restores mitochondrial biogenesis, bioenergetics, and function in NAFLD, and is accompanied by upregulation of antioxidant systems and alterations in lipid droplet architecture (smaller, more numerous LDs). RIPK3 deficiency upregulates LD-associated proteins PLIN1 and PLIN5.\",\n      \"method\": \"Ripk3−/− mice on CDAA diet, CRISPR-Cas9 Ripk3-null hepatocytes, mitochondrial function assays, lipid droplet imaging, proteomics\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse and cell model, multiple metabolic readouts, single lab\",\n      \"pmids\": [\"36029129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RIPK3 cleavage by caspase-8 at D333 is dispensable for blocking necroptosis during development (Ripk3D333A/D333A mice are viable), but caspase-8-mediated cleavage of RIPK3 restricts NLRP3 inflammasome activation, pyroptosis, and IL-1β secretion when IAPs are limiting.\",\n      \"method\": \"Knock-in mice (Ripk3D333A/D333A), cell death assays, NLRP3 inflammasome activation assays, IL-1β secretion\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — precise knock-in mouse model, defined mechanistic outcome separating necroptosis from inflammasome functions, rigorous controls\",\n      \"pmids\": [\"38514849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RIPK3-MLKL signaling drives STING pathway amplification: RIPK3 inhibits autophagic degradation of STING, while MLKL (when its pro-necroptotic membrane activity is blocked) binds activated STING and is secreted extracellularly to restrict TBK1 and IRF3 recruitment, thereby bidirectionally regulating STING signaling.\",\n      \"method\": \"RIPK3 KO HT29 cells, autophagy flux assays, STING co-immunoprecipitation with MLKL, cell death assays, in vivo sepsis model\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO cells with defined molecular pathway, Co-IP of MLKL-STING complex, single lab\",\n      \"pmids\": [\"37475188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"OASL undergoes liquid-liquid phase condensation upon viral infection and scaffolds RIPK3 and ZBP1 via protein-protein interactions, providing spatial segregation for RIPK3 nucleation. This OASL-driven liquid platform facilitates amyloid-like fibril formation and autophosphorylation of RIPK3, leading to MLKL phosphorylation and necroptosis. Oasl1-deficient mice show severely impaired necroptosis and uncontrolled viral dissemination.\",\n      \"method\": \"Phase condensation assays, co-immunoprecipitation, RIPK3 fibril formation assays, MLKL phosphorylation, Oasl1 KO mice with viral infection\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution of phase condensation, amyloid fibrillation assays, KO mouse validation, multiple orthogonal methods\",\n      \"pmids\": [\"36604592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PRMT1 methyltransferase methylates RIP3 at R486 (human) / R479 (mouse), and this methylation inhibits the RIP1-RIP3 interaction and suppresses necrosome complex formation, thereby blocking RIP3 phosphorylation and necroptosis activation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro methylation assays, methylation-deficient RIP3 mutant, RIP3-RIP1 interaction assays, necroptosis readouts, patient sample analysis with di-methylation-specific antibody\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro methylation and Co-IP showing direct mechanistic consequence, single lab\",\n      \"pmids\": [\"37005412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"p55γ promotes RIP3 proteasomal degradation in a ubiquitin-dependent manner, with MG53 functioning as the E3 ligase mediating p55γ-induced RIP3 degradation. HIF1α transcriptionally regulates p55γ expression. This p55γ-MG53-RIP3 axis underlies ischemic preconditioning-induced suppression of myocardial necroptosis.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, mass spectrometry, ChIP assays, p55γ transgenic and KO mice, cardiac I/R model\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and pulldown identifying MG53 as E3 ligase for RIP3, genetic mouse validation, single lab\",\n      \"pmids\": [\"37527538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ZBP1 senses mitochondrial Z-form DNA induced by diquat poisoning in endothelial cells and interacts with RIPK3, leading to RIPK3-dependent necroptosis and ferroptosis. RIPK3 has a dual role: it phosphorylates MLKL (necroptosis) and also phosphorylates FSP1 to inhibit its enzymatic activity (promoting ferroptosis). Specific deletion of Zbp1 or Ripk3 in endothelial cells simultaneously inhibits both death pathways.\",\n      \"method\": \"Endothelial cell-specific Zbp1 and Ripk3 KO mice, Z-DNA detection, MLKL phosphorylation assays, FSP1 phosphorylation and activity assays, organ damage readouts\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-specific KO with dual pathway dissection, identification of FSP1 as a novel RIPK3 substrate, multiple orthogonal methods\",\n      \"pmids\": [\"38493248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RIPK3 induces mitochondrial fission in diabetic podocytes via MLKL-PGAM5-Drp1 signaling: RIPK3 activates MLKL, which engages PGAM5 to promote phosphorylation and mitochondrial translocation of Drp1 (S616), causing mitochondrial fragmentation and dysfunction. Ripk3 KO mice are protected from DKD-associated albuminuria and podocyte loss.\",\n      \"method\": \"Ripk3 KO mice (DKD model), RIPK3 overexpression in podocytes, MLKL/PGAM5/Drp1 phosphorylation assays, mitochondrial imaging, single-cell RNA-seq\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model plus mechanistic pathway via MLKL-PGAM5-Drp1, single lab\",\n      \"pmids\": [\"39089491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RIP3 nuclear translocation and formation of a RIP3-AIF complex, followed by nuclear translocation of this complex, is critical for ischemic neuronal DNA degradation and programmed necrosis after global cerebral ischemia/reperfusion injury in rats.\",\n      \"method\": \"Necrostatin-1 treatment, immunoprecipitation, immunofluorescence co-localization, western blot in rat I/R model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-immunoprecipitation and co-localization in single rat model, single lab, no genetic KO confirmation\",\n      \"pmids\": [\"27377128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RIPK3-MLKL signaling activates mitochondrial CaMKII which drives phosphorylation of Smad2/3 and subsequent production of extracellular matrix proteins (αSMA, collagen 1α1) in response to TGF-β during chronic kidney disease. TGF-β induces translocation of RIPK3 and MLKL to mitochondria, causing mitochondrial dysfunction and ROS production that activates CaMKII.\",\n      \"method\": \"RIPK3 KO and MLKL KD experiments, mitochondrial fractionation, CaMKII inhibition, Smad2/3 phosphorylation assays, UUO model\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO/KD with defined downstream phosphorylation cascade, mitochondrial fractionation, single lab\",\n      \"pmids\": [\"35964866\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RIPK3 (RIP3) is a serine/threonine kinase that acts as the central hub of the necrosome: upon death receptor, TLR, or innate sensor (ZBP1/DAI) activation, RIPK3 assembles with RIPK1 via RHIM-domain-driven amyloid-like oligomerization into mosaic rod-shaped necrosomes, undergoes autophosphorylation (promoted by kinase-domain homodimerization), and phosphorylates MLKL at T224/S227 to drive its oligomerization, membrane translocation, and necroptotic cell death; beyond necroptosis, RIPK3 can also activate CaMKII (mediating mPTP opening in cardiac cells), promote NLRP3 inflammasome activation, drive NF-κB/Erk/IFN-β inflammatory signaling as a scaffold independently of its kinase activity, and phosphorylate FSP1 to promote ferroptosis, while its activity and stability are tightly regulated by multiple E3 ligases (PELI1, TRIM25, MG53) that mediate K48-ubiquitin-dependent proteasomal degradation, by inhibitory phosphorylation at S164/T165, and by caspase-8-mediated cleavage (which restrains NLRP3 but is dispensable for blocking necroptosis).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RIPK3 is a serine/threonine kinase that functions as the executioner hub of programmed necrosis (necroptosis) while also serving as a death-independent scaffold for inflammatory and metabolic signaling [#1, #2, #12]. It was first identified as a RIP1-binding kinase recruited to the TNFR1 complex [#0], and is now understood to assemble with RIPK1 through RHIM-dependent oligomerization into mosaic rod-shaped necrosomes in which alternating RIPK1 and RIPK3 oligomeric domains form; RIPK3 homo-oligomers of tetramer size or above provide the platform for downstream effector recruitment [#25]. Kinase-domain homodimerization through a RAF-like interface drives cis-autophosphorylation, and phosphorylation of a single RIPK3 molecule within a dimer is sufficient to license effector engagement [#5, #16]. Activating C-lobe phosphorylation at T224/S227 mediates stable recruitment of MLKL — an essential checkpoint preceding MLKL phosphorylation — which then disengages from RIPK3 via a pseudokinase-domain conformational transition to execute membrane permeabilization, while activation-loop phosphorylation at S164/T165 negatively regulates kinase activity [#24, #23]. Beyond MLKL, RIPK3 phosphorylates additional substrates to drive distinct death and signaling outcomes: CaMKII to open the mitochondrial permeability transition pore in cardiac necroptosis [#9], and FSP1 to promote ferroptosis downstream of ZBP1-sensed mitochondrial Z-DNA [#32]. RIPK3 nucleation can be spatially organized by an OASL liquid-liquid phase-separated platform during viral infection that facilitates its amyloid-like fibrillation and autophosphorylation [#29]. Independently of its kinase activity and of MLKL, RIPK3 acts as a scaffold to drive Erk/cFos/NF-\\u03baB and IFN-\\u03b2 inflammatory programs, NLRP3 inflammasome activation, and ubiquitin-dependent cytokine production, and restricts viral pathogenesis through immunometabolic routes such as IRG1/itaconate induction [#11, #13, #8, #21, #18, #12]. RIPK3 abundance and activity are tightly restrained by multiple K48-ubiquitin E3 ligases that target it for proteasomal degradation — PELI1 (via T182 phosphorylation\\u2013dependent recognition and K363 ubiquitination), TRIM25 (K501), and MG53 — by PRMT1-mediated arginine methylation that blocks the RIP1-RIP3 interaction, and by caspase-8 cleavage at D333, which restrains NLRP3 activation but is dispensable for blocking necroptosis [#14, #20, #31, #30, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established RIPK3's foundational identity as a RIP1-binding kinase, defining the physical link that would later prove central to necrosome assembly.\",\n      \"evidence\": \"Co-IP, overexpression, and NF-\\u03baB reporter assays mapping RIP3-RIP1 binding via the unique C-terminus at the TNFR1 complex\",\n      \"pmids\": [\"10358032\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify necroptosis as RIPK3's function\", \"MLKL and downstream effectors not yet known\", \"Overexpression-induced apoptosis phenotype not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined RIPK3 as an in vivo driver of virus-associated necrosis and showed this death can proceed independently of RIP1, broadening RIPK3 beyond canonical TNF necroptosis.\",\n      \"evidence\": \"RIP3-deficient mice in MCMV infection with viral vIRA inhibitor mapping to RIP3-RIP1 RHIM interactions\",\n      \"pmids\": [\"20413098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MLKL not yet identified as effector\", \"Molecular trigger of RIP1-independent death unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated via clean genetic epistasis that RIPK3-dependent necrosis drives tissue inflammation when apoptotic (FADD) signaling is removed, establishing physiological relevance.\",\n      \"evidence\": \"FADD IEC-KO \\u00d7 RIP3 KO double-knockout mice with intestinal histopathology\",\n      \"pmids\": [\"21804564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the molecular execution step downstream of RIPK3\", \"Relationship to caspase-8 restraint not yet detailed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Probed the breadth of RIPK3 kinase output, indicating substrates beyond direct necroptotic effectors and a candidate phosphorylation motif.\",\n      \"evidence\": \"SILAC quantitative phosphoproteomics comparing RIP3+/+ vs RIP3\\u2212/\\u2212 macrophages and MEFs\",\n      \"pmids\": [\"22942356\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific physiological substrates not individually validated\", \"Direct vs indirect phosphorylation not distinguished\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified activating (RIPK3 S204) and inhibitory (RIPK1 S89) phosphosites, beginning the dissection of phospho-regulation governing necrosis initiation.\",\n      \"evidence\": \"Site-directed mutagenesis with phosphomimetics, kinase activity and cell death assays\",\n      \"pmids\": [\"24059293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous kinase responsible for S204 phosphorylation not defined\", \"Structural basis of activation not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved the activation mechanism: RIPK3 homo-dimerization/oligomerization drives autophosphorylation sufficient for MLKL recruitment, while RIPK1 both activates and restrains RIPK3 and caspase-8 controls dimer propagation.\",\n      \"evidence\": \"Chemical-inducible FKBP/rapamycin dimerization systems, RIPK1 KO cells, phosphorylation and cell-death readouts (two studies)\",\n      \"pmids\": [\"24902902\", \"24902904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural interface of dimerization not yet defined\", \"Mechanism of caspase-8 control of dimer stability unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Distinguished RIPK3's catalytic from scaffold/allosteric functions, showing kinase-dead D161N forces a RIP3-FADD-caspase-8-cFLIP apoptotic complex while K51A does not, explaining divergent mouse lethality.\",\n      \"evidence\": \"Selective RIP3 kinase inhibitors, kinase-dead and RHIM mutants, complex Co-IP, knock-in mice\",\n      \"pmids\": [\"25459880\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Allosteric basis of D161N gain-of-function not yet structurally explained (addressed later)\", \"How inhibitors flip output to apoptosis at high dose incompletely defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Separated kinase-dependent from kinase-independent RIPK3 control of NLRP3 inflammasome activation, contingent on IAP and caspase-8 status.\",\n      \"evidence\": \"IAP-, caspase-8-, MLKL-, RIPK3-KO combinations with LPS, inflammasome assays, in vivo arthritis\",\n      \"pmids\": [\"25693118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RIPK3 scaffold partners for inflammasome assembly not fully mapped\", \"Role of RIPK3/MLKL ubiquitylation mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Uncovered RIPK3 death-independent inflammatory signaling, driving Erk/cFos/NF-\\u03baB and CaMKII-mPTP cardiac necroptosis via non-MLKL substrate routes.\",\n      \"evidence\": \"Kinase inhibitors, RIP3 KO mice, LPS macrophage stimulation, cardiac I/R and doxorubicin models, CaMKII Co-IP and phosphorylation assays\",\n      \"pmids\": [\"27396959\", \"26726877\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect CaMKII phosphorylation not fully resolved\", \"Scaffold partners for Erk/NF-\\u03baB activation not enumerated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated death-independent neuroinflammatory and IFN-\\u03b2 signaling roles of RIPK3, where MLKL is dispensable but necrosome-like aggregates support TRIF signaling.\",\n      \"evidence\": \"Ripk3\\u2212/\\u2212 vs Mlkl\\u2212/\\u2212 mice in WNV infection, chemokine/flow cytometry; macrophage IFN-\\u03b2 assays\",\n      \"pmids\": [\"28366204\", \"28461567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular composition of signaling-competent aggregates not defined\", \"Transcriptional targets driving chemokine output not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the structural basis of RIPK3 activation and a dedicated degradative brake, linking kinase-domain dimerization to cis-autophosphorylation and PELI1-mediated K48 degradation of active RIPK3.\",\n      \"evidence\": \"Structural analysis with dimer-interface mutagenesis and knock-in mice; Co-IP, in vitro ubiquitination and kinase assays mapping T182/K363\",\n      \"pmids\": [\"30131368\", \"29883609\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of physiological E3 ligases not yet enumerated (extended later)\", \"Quantitative kinetics of dimerization-coupled autophosphorylation not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended RIPK3 into non-necroptotic metabolic and immunomodulatory disease pathways, acting through AKT-ACL in fibrosis and ROS/caspase-1/PPAR\\u03b3 in tumor macrophage polarization.\",\n      \"evidence\": \"RIPK3 KO vs MLKL KO fibrosis models, TGF-\\u03b21 fibroblast assays; RIPK3 KO TAMs with PPAR\\u03b3 cleavage and polarization readouts\",\n      \"pmids\": [\"29415885\", \"32122992\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct RIPK3 substrates in these axes not identified\", \"Whether RIPK3 acts catalytically or as scaffold in fibrosis not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established RIPK3 as an immunometabolic antiviral effector via the ZBP1-IRG1-itaconate axis and identified CK1\\u03b3 as a necrosome-associated RIPK3 kinase.\",\n      \"evidence\": \"ZBP1/RIPK3 KO mice in Zika infection with metabolomics; gain-of-function kinase screen plus in vitro kinase assays for CK1\\u03b3\",\n      \"pmids\": [\"30635240\", \"31801942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RIPK3 substrate driving IRG1 induction not defined\", \"Functional consequence of CK1\\u03b3-mediated RIPK3 phosphorylation incompletely mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Expanded the degradative control of RIPK3 stability through TRIM25-mediated K48 ubiquitination at K501 and proteasome-coupled fate decisions.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, TRIM25 KO cells, K501R mutagenesis; proteasome inhibitor studies with K264R mutants\",\n      \"pmids\": [\"33953350\", \"26786097\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro reconstitution of TRIM25-RIPK3 ubiquitination\", \"Hierarchy among PELI1/TRIM25 ubiquitination events unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined viral and host strategies controlling RIPK3 — orthopoxvirus vIRD hijacks SCF to degrade RIPK3, while ZBP1 uses RIPK1/RIPK3 as scaffolds for cIAP1/LUBAC-driven ubiquitin signaling independent of kinase activity.\",\n      \"evidence\": \"siRNA screen, Co-IP, ubiquitination assays, RIPK3/MLKL KO mice for vIRD; ubiquitin chain-type analysis and cytokine assays in HT29 cells for ZBP1\",\n      \"pmids\": [\"33444549\", \"36268590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous counterpart of vIRD-targeted degradation pathway not fully defined\", \"Scaffolding stoichiometry within the ZBP1 complex unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Refined the activation code and supramolecular architecture: T224/S227 govern stable MLKL recruitment, S164/T165 inhibit kinase activity, MLKL disengages via conformational change, and necrosomes are mosaic rod-shaped RIP1/RIP3 oligomer assemblies; caspase-8 cleavage at D333 restrains NLRP3 but not necroptosis.\",\n      \"evidence\": \"Phosphoproteomics and systematic phosphosite mutagenesis in HT29; MLKL crystal structures with monobodies; super-resolution STORM/PALM imaging; Ripk3 D333A knock-in mice\",\n      \"pmids\": [\"35739084\", \"33850121\", \"35256774\", \"38514849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for inhibitory S164/T165 not assigned\", \"Trigger for MLKL disengagement timing not fully defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked RIPK3 to mitochondrial and lipid metabolic remodeling in liver and kidney disease, partly through RIPK3-MLKL-CaMKII-Smad2/3 fibrotic signaling and effects on mitochondrial biogenesis and lipid droplets.\",\n      \"evidence\": \"Ripk3\\u2212/\\u2212 mice (NAFLD/CDAA), CRISPR hepatocytes, proteomics, LD imaging; mitochondrial fractionation and CaMKII/Smad2/3 assays in UUO\",\n      \"pmids\": [\"36029129\", \"35964866\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether metabolic effects are catalytic or scaffold-dependent unresolved\", \"Direct molecular target initiating mitochondrial translocation not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified spatial and post-translational regulators of RIPK3 nucleation: OASL phase condensation scaffolds RIPK3 fibrillation, PRMT1 arginine methylation (R486) blocks the RIP1-RIP3 interaction, and MG53/p55\\u03b3 mediate proteasomal degradation in cardiac protection.\",\n      \"evidence\": \"Phase condensation and fibril assays with Oasl1 KO mice; in vitro methylation and Co-IP for PRMT1; Co-IP/MS, ChIP and transgenic mice for p55\\u03b3-MG53 axis\",\n      \"pmids\": [\"36604592\", \"37005412\", \"37527538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between methylation and degradation control not integrated\", \"How OASL condensates are dissolved/regulated unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established RIPK3 as a dual death-pathway effector, phosphorylating FSP1 to promote ferroptosis alongside MLKL-driven necroptosis, and driving MLKL-PGAM5-Drp1 mitochondrial fission in diabetic kidney disease.\",\n      \"evidence\": \"Endothelial-specific Zbp1/Ripk3 KO mice with FSP1 phosphorylation/activity assays; Ripk3 KO DKD model with PGAM5/Drp1 phosphorylation and mitochondrial imaging\",\n      \"pmids\": [\"38493248\", \"39089491\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FSP1 phosphosite(s) not precisely mapped\", \"Determinants selecting necroptosis vs ferroptosis output not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RIPK3 selects among its diverse outputs — necroptosis, ferroptosis, CaMKII/mPTP death, and kinase-independent inflammatory scaffolding — at a single molecular hub remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking substrate choice to upstream stimulus or complex composition\", \"Quantitative rules governing scaffold vs catalytic mode not established\", \"Integration of competing E3 ligases and methylation in setting RIPK3 levels not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 9, 16, 24, 32]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [5, 16, 24, 32]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [11, 13, 21]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 25]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [9, 33, 35]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 2, 5, 24, 32]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 11, 12, 13, 18, 21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 13, 28]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [14, 20, 27, 30, 31]}\n    ],\n    \"complexes\": [\"necrosome (RIPK1-RIPK3-MLKL)\", \"RIP3-FADD-caspase-8-cFLIP complex\", \"ZBP1-RIPK1-RIPK3-cIAP1-LUBAC complex\"],\n    \"partners\": [\"RIPK1\", \"MLKL\", \"ZBP1\", \"PELI1\", \"TRIM25\", \"CaMKII\", \"FSP1\", \"OASL\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}